Market revenue in 2023 | USD 31.1 million |
Market revenue in 2030 | USD 54.4 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsourcing |
Key market players worldwide | Genpact Ltd, Criterium Inc., Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Holdings Inc, FREYR Battery Inc, Pharmexon, Cambridge Design Partnership, Voisin Consulting Life Sciences, Accell, PAREXEL, Promedica International, PharmaLex, NDA Regulatory Service GmbH, QVigilance, BlueReg Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.2% in 2023. Horizon Databook has segmented the Chile regulatory affairs market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
In Chile, Public Health Institute and the Ministry of Health are the two major regulatory authorities, which are responsible for the enforcement of regulations for pharmaceutical products, biologicals, & medical devices.
The pharmaceutical & biotechnology products and medical devices are governed by the Sanitary Code and require sanitary registration (i.e., marketing authorization) to be imported, distributed, and/or used for any purpose in the country.
Chile has a well-organized, effectively governed health system & infrastructure and has introduced several reforms to meet the country’s medical needs. Since the implementation of the United States–Chile Free Trade Agreement in 2004, majority of medical devices can enter the country duty free with U.S. certificate of origin.
Horizon Databook provides a detailed overview of country-level data and insights on the Chile regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into Chile regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account